Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > NML's recommendation would be extremely credible

<< Previous

Bullboard Posts

Next >>

Comment by ScienceFirston Sep 15, 2022 11:24am

282 Views

Post# 34964477

RE:RE:NML's recommendation would be extremely credible

Moderna has a complete different platform (mRNA). They are aiming 3 markets with it; vaccine, diagnosis and therapeutics.

TLT has more chances to attract a big pharma that already has its entries in urologist offices and that would want to step in in the vaccine market. Or TLT could jv individually per indications/markets (urology, pulmonary, neurology, vaccines, etc ...) like many biotechs do until they get acquired.

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec